CARDIOPROTECTION
- 1 September 1999
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (4) , 860-869
- https://doi.org/10.1046/j.1365-2141.1999.01544.x
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Cytoprotection in the treatment of pediatric cancer: Review of current strategies in adults and their application to childrenMedical and Pediatric Oncology, 1999
- Oncologic Agents in Sterically Stabilized Liposomes: Basic ConsiderationsPublished by Springer Nature ,1998
- Mechanisms for anthracycline-induced cardiomyopathy: clinical and laboratory correlationsProgress in Pediatric Cardiology, 1997
- Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties?European Journal Of Cancer, 1996
- Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.Journal of Clinical Oncology, 1995
- Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive NodesJAMA, 1995
- Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.Heart, 1993
- Strategies for prevention of anthracycline cardiotoxicityCancer Treatment Reviews, 1993
- Clinically useful doxorubicin analoguesCancer Treatment Reviews, 1987
- Dose-effect and structure-function relationships in doxorubicin cardiomyopathyAmerican Heart Journal, 1981